HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4/NF-κB signaling pathway
- 15 May 2020
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 880, 173189
- https://doi.org/10.1016/j.ejphar.2020.173189
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Modulation of P-glycoprotein in rat brain microvessel endothelial cells under oxygen glucose deprivationJournal of Pharmacy and Pharmacology, 2013
- p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypesThe Journal of cell biology, 2013
- Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brainProceedings of the National Academy of Sciences of the United States of America, 2012
- NF-κB, the first quarter-century: remarkable progress and outstanding questionsGenes & Development, 2012
- The Role of Cerebral Vascular NFĸB in LPS-induced Inflammation: Differential Regulation of Efflux Transporter and Transporting Cytokine ReceptorsCellular Physiology and Biochemistry, 2010
- Neuronal mdr-1 gene expression after experimental focal hypoxia: A new obstacle for neuroprotection?Journal of the Neurological Sciences, 2007
- The role of inflammation in CNS injury and diseaseBritish Journal of Pharmacology, 2006
- Rapid Modulation of P-Glycoprotein-Mediated Transport at the Blood-Brain Barrier by Tumor Necrosis Factor-α and LipopolysaccharideMolecular Pharmacology, 2005
- Rapid Regulation of P-Glycoprotein at the Blood-Brain Barrier by Endothelin-1Molecular Pharmacology, 2004
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989